Friends Medichem's Cutting-Edge API Unit Takes Root in Gujarat

Friends Medichem is set to establish an Active Pharmaceutical Intermediates (APIs) Manufacturing Unit in Pipaliya, Rajkot, Gujarat, with a budget of Rs. 13 crore. Spanning across 2625 square meters of land, the project will allot approximately 870 square meters, around 33% of the total area, as a green zone, underscoring the company's commitment to sustainability. With a proposed monthly production capacity of 12 metric tons of APIs and pharmaceutical intermediates, the project aims to contribute significantly to India's pharmaceutical sector.

While the specific types of APIs and intermediates are not detailed, the project aligns with national goals by potentially reducing India's reliance on imported APIs and catering to domestic demand. The establishment is anticipated to have a positive economic impact by creating employment opportunities, fostering revenue generation, and potentially contributing to local infrastructure development. Unfortunately, details regarding the project's timeline and current status are not provided, leaving uncertainty about its progress and completion stage. Nonetheless, the unit's focus on sustainability, coupled with its substantial production capacity, signals potential advancements and growth within India's pharmaceutical industry.

As on January, 2024. The project has approvals. All approvals were obtained. Project development begins in March 2024.

News by Rahul Yelligetti